BioSpace News Archive

BioMidwest

UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

Inspire Medical Systems, Inc. announced that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.

May 3, 2023
·
1 min read
Business

RAPT Therapeutics Announces the Appointment of Michael Listgarten as General Counsel

RAPT Therapeutics, Inc. today announced the appointment of Michael Listgarten as General Counsel.

May 3, 2023
·
4 min read
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration

Ceapro Inc. announced positive results from a research collaboration with the Angiogenesis Foundation conducted with colleagues at the University of Arizona.

May 3, 2023
·
4 min read
Magenta Medical Closes $55M Funding Round Led by OrbiMed

Magenta Medical, developer of the world’s smallest heart pump, announced a $55M financing round led by global healthcare investment manager OrbiMed, with participation from existing investors New Enterprise Associates, Pitango VC, and ALIVE - Israel HealthTech Fund.

May 3, 2023
·
5 min read
Resilia Pharmaceuticals Announces Return to Market of Neosalus® Cream and Neosalus® Lotion

Resilia Pharmaceuticals, Inc. announced today that it has brought Neosalus® Cream and Neosalus® Lotion back to the market.

May 3, 2023
·
4 min read
Drug Development

PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

PharmaEssentia USA Corporation today announced that the first patients are now being dosed in ECLIPSE PV, a Phase 3b clinical study evaluating an accelerated dosing schedule for ropeginterferon alfa-2b-njft using a prefilled syringe for the treatment of adults with polycythemia vera (PV).

May 3, 2023
·
7 min read
Genetown

Alnylam Issues 2022 Corporate Responsibility Report

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its 2022 Corporate Responsibility Report.

May 3, 2023
·
3 min read
BioMidwest

Gate Neurosciences Hones in on Precision Medicine with Expanded Research Operations Supporting Its Synaptic Function-Enhancing Molecules

Gate Neurosciences announced it has increased its R&D capabilities with new expanded research operations and lab facilities in Evanston, Illinois.

May 3, 2023
·
4 min read
Business

EvoEndo Elects David Pierce to the Board of Directors

EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our Board of Directors.

May 3, 2023
·
1 min read
Genetown

SeQure Dx to present at American Society of Gene and Cell Therapy (ASGCT) on the importance of incorporating population heterogeneity evaluation into gene editing and cell therapy off-target analyses

SeQure Dx, Inc announced today it will present new data at the 2023 American Society of Gene and Cell Therapy Annual Meeting from May 16 - 20 in Los Angeles.

May 3, 2023
·
2 min read